Alzheimer's Disease

A new study has found that light therapy applied to mice during deep sleep increased the brain’s ability to clear away beta-amyloid protein, which may lead to a drug-free, non-invasive treatment for Alzheimer's disease.

Researchers have gained new insights into largely overlooked circular RNAs in brain cells and the crucial role they play in diseases like Alzheimer’s and Parkinson’s, opening the door to developing diagnostic tests and treatments for them.

There’s growing recognition that attention-deficit hyperactive disorder is not just a childhood disruptive behavior condition. Yet older adults, aged 50 and over, are not only consistently absent from ADHD studies, but face roadblocks in seeking help.

Physicists have combined nanotechnology, artificial intelligence and molecular biology to design a novel method that can detect Alzheimer’s disease protein markers in blood that are the tell-tale signs of early neurodegeneration.

Researchers have found that an intranasal drug, currently being tested as an MS treatment, reduced brain inflammation and improved cognition in mice with Alzheimer’s disease, independent of the amount of beta-amyloid plaques present.

Two studies have used focused ultrasound to open up the blood-brain barrier, generating a positive immune response and allowing for the admission of gene-editing technology. The technique could be a non-invasive way of treating neurodegenerative diseases.

Scientists have discovered how a unique kind of cell death, due to iron toxicity, creates a snowball effect that advances cognitive decline. With this finding, a whole new approach to treatment could be developed.

While effective in treating sleep apnea, continuous positive airway pressure (CPAP) machines are intrusive and disruptive, which is why 50% of patients give up on using the life-saving devices. A new study shows why they might be worth the discomfort.

In an effort to find new treatments to halt the progression of Alzheimer's disease, scientists have landed on a molecule that can dial down the process that produces brain inflammation – something believed to be inextricably linked to cognitive decline.

For the first time, scientists have identified a marker in the retina that may lead to Parkinson’s disease, and it can be detected early, which could be life-changing for those at risk of developing this or other degenerative conditions.

Six million Americans are living with Alzheimer’s disease, and with it comes the physical behaviors that are responsible for 80% of nursing home admissions. Researchers believe fasting set to circadian rhythms could alleviate these awful side effects.

A study last year found that the influenza vaccine reduced the risk of Alzheimer's disease. Now, the same research team has found that people aged 65 and over who’ve received routine vaccinations are significantly less likely to develop the condition.